Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial

Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial

This study assessed the safety and efficacy of three different doses of BoNT-A for persistent myofascial pain (MFP). One hundred female subjects were randomly assigned into five groups (<i>n</i> = 20): oral appliance (OA), saline solution (SS) and three BoNT-A groups with different doses...

Full description

Bibliographic Details
Main Authors: Giancarlo De la Torre Canales, Natalia Alvarez-Pinzon, Victor Ricardo Manuel Muñoz-Lora, Leonardo Vieira Peroni, Amanda Farias Gomes, Alfonso Sánchez-Ayala, Francisco Haiter-Neto, Daniele Manfredini, Célia Marisa Rizzatti-Barbosa
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Toxins
Subjects:
temporomandibular disorders
myofascial pain
botulinum toxin type A
bone loss
chronic pain
Online Access:https://www.mdpi.com/2072-6651/12/6/395

Similar Items

Similar Items